Form 8-K VERACYTE, INC. For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Veracyte, Inc (VCYT) PT Lowered to $28 at Morgan Stanley
August 8, 2025 2:49 PM EDTMorgan Stanley analyst Tejas Savant lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $28.00 (from $29.00) while maintaining a Underweight rating.
The analyst comments "Solid 2Q beat on continued Decipher/Afirma momentum leading to '25 guidance raise; total company guidance now initiated following Veracyte SAS... More
